Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|July 27, 2016
Diffuse Large-Cell Lymphoma in the Elderly: Does a Clinically Indolent Subset Exist?M Lishner, D Amato, B J Fernandes, et al.
Current Oncology (Toronto, Ont.)|December 10, 2014
Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitorsV Hirsh, N Blais, R Burkes, et al.
Current Oncology (Toronto, Ont.)|February 14, 2014
Impact of granulocyte colony-stimulating factors in metastatic colorectal cancer patientsA Amadio, R Burkes, T Bailie, et al.
American Journal of Clinical Oncology|October 1, 1986
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lungF A Shepherd, W K Evans, R Burkes, et al.
Lung Cancer (Amsterdam, Netherlands)|February 1, 1996
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary reportF A Shepherd, R Burkes, Y Cormier, et al.
Clinical Nuclear Medicine|August 1, 1994
Scintigraphic flare in skeletal lymphomaL M White, B G Gray, M Ichise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable doseF A Shepherd, R Burkes, Y Cormier, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1991
Prospective assessment of cardiac function in patients with Kaposi's sarcoma and the acquired immune deficiency syndromeJ A Herst, F A Shepherd, P Liu, et al.
Seminars in Oncology|June 1, 1997
Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancerF A Shepherd, Y Cormier, R Burkes, et al.
Pageof 3